CLINICAL TRIALS PROFILE FOR ADASUVE
✉ Email this page to a colleague
All Clinical Trials for adasuve
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00444028 ↗ | Staccato Loxapine Single Dose PK | Completed | Alexza Pharmaceuticals, Inc. | Phase 1 | 2005-09-01 | The objective of this study was to assess the safety, tolerability and pharmacokinetics of a single inhaled dose of (administered in 1 or 2 puffs) Staccato Loxapine in healthy volunteers. |
| NCT00489476 ↗ | Staccato Loxapine in Migraine (in Clinic) | Completed | Alexza Pharmaceuticals, Inc. | Phase 2 | 2007-06-01 | The objective of this trial is to assess the efficacy and safety of Staccato Loxapine in patients with migraine headache with or without aura in a clinical setting. |
| NCT00543062 ↗ | Staccato Prochlorperazine Thorough QT/QTc | Completed | Alexza Pharmaceuticals, Inc. | Phase 1 | 2007-10-01 | To assess the safety of Staccato Prochlorperazine on cardiac repolarization (QTc interval duration) at 2 dose levels compared to placebo in healthy volunteers. |
| NCT00628589 ↗ | Staccato Loxapine in Agitated Patients With Schizophrenia | Completed | Alexza Pharmaceuticals, Inc. | Phase 3 | 2008-02-01 | Phase 3 safety and efficacy study of Staccato Loxapine in the treatment of acute agitation in schizophrenic patients |
| NCT00825500 ↗ | Staccato Loxapine in Migraine (Out Patient) | Completed | Alexza Pharmaceuticals, Inc. | Phase 2 | 2009-01-01 | Assess the safety and efficacy of Staccato Loxapine in patients with moderate to severe migraine headache with or without aura in an outpatient setting. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for adasuve
Condition Name
Clinical Trial Locations for adasuve
Trials by Country
Clinical Trial Progress for adasuve
Clinical Trial Phase
Clinical Trial Sponsors for adasuve
Sponsor Name
